Resistant pathogens, fungi, and viruses

Surgical Clinics of North America

Volumn 94, Issue 6, 2014, Pages 1195-1218

  Guidry, Christopher A ^a   Mansfield, Sara A ^b   Sawyer, Robert G ^a   Cook, Charles H ^c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Bacteria; Fungi; Resistance; Surgery; Viruses

Indexed keywords

ACICLOVIR; GANCICLOVIR; ANTIVIRUS AGENT;

ANTIVIRAL THERAPY; BURN; CANDIDA; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; COMMUNITY ACQUIRED INFECTION; ENTEROBACTERIACEAE INFECTION; ENTEROCOCCAL INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FUNGUS; GASTROINTESTINAL DISEASE; HEART SURGERY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HERPES VIRUS INFECTION; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; INVASIVE CANDIDIASIS; LATENT PERIOD; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPSIS; SURGICAL PATIENT; VANCOMYCIN RESISTANT ENTEROCOCCUS; VIRUS REACTIVATION; VIRUS RESISTANCE; ANTIBIOTIC RESISTANCE; CANDIDIASIS; CROSS INFECTION; HERPESVIRIDAE INFECTIONS; MICROBIOLOGY; RISK FACTOR; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION; VIROLOGY;

ANTIVIRAL AGENTS; CANDIDIASIS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; HERPESVIRIDAE INFECTIONS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION; VANCOMYCIN-RESISTANT ENTEROCOCCI;

EID: 84923649258     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2014.08.010     Document Type: Review

References (177)

1. David M.Z., Daum R.S. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 2010, 23:616-687.
2. Boucher H.W., Corey G.R. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008, 46(Suppl 5):S344-349.
3. Goyal N., Miller A., Tripathi M., et al. Methicillin-resistant Staphylococcus aureus (MRSA): colonisation and pre-operative screening. Bone Joint J 2013, 95-B:4-9.
4. Hansra N.K., Shinkai K. Cutaneous community-acquired and hospital-acquired methicillin-resistant Staphylococcus aureus. Dermatol Ther 2011, 24:263-272.
5. Eells S.J., McKinnell J.A., Wang A.A., et al. Acomparison of clinical outcomes between healthcare-associated infections due to community-associated methicillin-resistant Staphylococcus aureus strains and healthcare-associated methicillin-resistant S. aureus strains. Epidemiol Infect 2013, 141:2140-2148.
6. Jain R., Kralovic S.M., Evans M.E., et al. Veterans affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. NEngl J Med 2011, 364:1419-1430.
7. McKinnell J.A., Huang S.S., Eells S.J., et al. Quantifying the impact of extranasal testing of body sites for methicillin-resistant Staphylococcus aureus colonization at the time of hospital or intensive care unit admission. Infect Control Hosp Epidemiol 2013, 34:161-170.
8. Edgeworth J.D. Has decolonization played a central role in the decline in UK methicillin-resistant Staphylococcus aureus transmission? A focus on evidence from intensive care. JAntimicrob Chemother 2011, 66(Suppl 2):ii41-47.
9. Otter J.A., Herdman M.T., Williams B., et al. Low prevalence of methicillin-resistant Staphylococcus aureus carriage at hospital admission: implications for risk-factor-based vs universal screening. JHosp Infect 2013, 83:114-121.
10. Kassakian S.Z., Mermel L.A., Jefferson J.A., et al. Impact of chlorhexidine bathing on hospital-acquired infections among general medical patients. Infect Control Hosp Epidemiol 2011, 32:238-243.
11. Rupp M.E., Cavalieri R.J., Lyden E., et al. Effect of hospital-wide chlorhexidine patient bathing on healthcare-associated infections. Infect Control Hosp Epidemiol 2012, 33:1094-1100.
12. Climo M.W., Yokoe D.S., Warren D.K., et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. NEngl J Med 2013, 368:533-542.
13. Evans H.L., Dellit T.H., Chan J., et al. Effect of chlorhexidine whole-body bathing on hospital-acquired infections among trauma patients. Arch Surg 2010, 145:240-246.
14. Ridenour G., Lampen R., Federspiel J., et al. Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients. Infect Control Hosp Epidemiol 2007, 28:1155-1161.
15. Huang S.S., Septimus E., Kleinman K., et al. Targeted versus universal decolonization to prevent ICU infection. NEngl J Med 2013, 368:2255-2265.
16. Maree C.L., Daum R.S., Boyle-Vavra S., et al. Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerg Infect Dis 2007, 13:236-242.
17. Odell C.A. Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) skin infections. Curr Opin Pediatr 2010, 22:273-277.
18. Chua K., Laurent F., Coombs G., et al. Antimicrobial resistance: not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA-its evolving antimicrobial resistance and implications for therapy. Clin Infect Dis 2011, 52:99-114.
19. Wang J.T., Liao C.H., Fang C.T., et al. Incidence of and risk factors for community-associated methicillin-resistant Staphylococcus aureus acquired infection or colonization in intensive-care-unit patients. JClin Microbiol 2010, 48:4439-4444.
20. Otter J.A., French G.L. Community-associated meticillin-resistant Staphylococcus aureus: the case for a genotypic definition. JHosp Infect 2012, 81:143-148.
21. Skov R., Christiansen K., Dancer S.J., et al. Update on the prevention and control of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA). Int J Antimicrob Agents 2012, 39:193-200.
22. Karampela I., Poulakou G., Dimopoulos G. Community acquired methicillin resistant Staphylococcus aureus pneumonia: an update for the emergency and intensive care physician. Minerva Anestesiol 2012, 78:930-940.
23. Wiersma P., Tobin D'Angelo M., Daley W.R., et al. Surveillance for severe community-associated methicillin-resistant Staphylococcus aureus infection. Epidemiol Infect 2009, 137:1674-1678.
24. Gillet Y., Vanhems P., Lina G., et al. Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clin Infect Dis 2007, 45:315-321.
25. Mazuski J.E. Vancomycin-resistant enterococcus: risk factors, surveillance, infections, and treatment. Surg Infect (Larchmt) 2008, 9:567-571.
26. Nguyen G.C., Leung W., Weizman A.V. Increased risk of vancomycin-resistant enterococcus (VRE) infection among patients hospitalized for inflammatory bowel disease in the United States. Inflamm Bowel Dis 2011, 17:1338-1342.
27. Whang D.W., Miller L.G., Partain N.M., et al. Systematic review and meta-analysis of linezolid and daptomycin for treatment of vancomycin-resistant enterococcal bloodstream infections. Antimicrob Agents Chemother 2013, 57:5013-5018.
28. Napolitano L.M. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci. Surg Infect (Larchmt) 2005, 6(Suppl 2):S-5-S-22.
29. Kim Y.J., Kim S.I., Kim Y.R., et al. Risk factors for vancomycin-resistant enterococci infection and mortality in colonized patients on intensive care unit admission. Am J Infect Control 2012, 40:1018-1019.
30. Kanj S.S., Kanafani Z.A. Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa. Mayo Clin Proc 2011, 86:250-259.
31. Vardakas K.Z., Tansarli G.S., Rafailidis P.I., et al. Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum beta-lactamases: a systematic review and meta-analysis. JAntimicrob Chemother 2012, 67:2793-2803.
32. Pitout J.D. Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 2010, 70:313-333.
33. Centers for Disease Control and Prevention (CDC) Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep 2013, 62:165-170.
34. Gupta N., Limbago B.M., Patel J.B., et al. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011, 53:60-67.
35. Schechner V., Kotlovsky T., Kazma M., et al. Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected?. Clin Microbiol Infect 2013, 19:451-456.
36. Marchaim D., Chopra T., Bhargava A., et al. Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship. Infect Control Hosp Epidemiol 2012, 33:817-830.
37. Rosenberger L.H., Hranjec T., Politano A.D., et al. Effective cohorting and "superisolation" in a single intensive care unit in response to an outbreak of diverse multi-drug-resistant organisms. Surg Infect (Larchmt) 2011, 12:345-350.
38. Zimmerman F.S., Assous M.V., Bdolah-Abram T., et al. Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge. Am J Infect Control 2013, 41:190-194.
39. van Duin D., Kaye K.S., Neuner E.A., et al. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. Diagn Microbiol Infect Dis 2013, 75:115-120.
40. Pfaller M., Neofytos D., Diekema D., et al. Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance(R)) registry, 2004-2008. Diagn Microbiol Infect Dis 2012, 74:323-331.
41. Silva S., Negri M., Henriques M., et al. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev 2012, 36:288-305.
42. Eggimann P., Bille J., Marchetti O. Diagnosis of invasive candidiasis in the ICU. Ann Intensive Care 2011, 1:37.
43. Eggimann P., Garbino J., Pittet D. Management of Candida species infections in critically ill patients. Lancet Infect Dis 2003, 3:772-785.
44. Gleason T.G., May A.K., Caparelli D., et al. Emerging evidence of selection of fluconazole-tolerant fungi in surgical intensive care units. Arch Surg 1997, 132:1197-1201.
45. Playford E.G., Eggimann P., Calandra T. Antifungals in the ICU. Curr Opin Infect Dis 2008, 21:610-619.
46. Whitley R.J., Roizman B. Herpes simplex virus infections. Lancet 2001, 357:1513-1518.
47. Stone R.C., Micali G.A., Schwartz R.A. Roseola infantum and its causal human herpesviruses. Int J Dermatol 2014, 53:397-403.
48. Butterly A., Schmidt U., Wiener-Kronish J. Methicillin-resistant Staphylococcus aureus colonization, its relationship to nosocomial infection, and efficacy of control methods. Anesthesiology 2010, 113:1453-1459.
49. Mesri E.A., Cesarman E., Boshoff C. Kaposi's sarcoma and its associated herpesvirus. Nat Rev Cancer 2010, 10:707-719.
50. Jenson H.B. Epstein-Barr virus. Pediatr Rev 2011, 32:375-383. [quiz: 384].
51. Cannon M.J., Schmid D.S., Hyde T.B. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 2010, 20:202-213.
52. Bilimoria K.Y., Liu Y., Paruch J.L., et al. Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. JAm Coll Surg 2013, 217:833-842.e1-3.
53. Sinclair J. Human cytomegalovirus: latency and reactivation in the myeloid lineage. JClin Virol 2008, 41:180-185.
54. Duan S., Yang Y.C., Xiang L.F., et al. Incidence and risk factors of HIV infection among sero-negative spouses of HIV patients in Dehong prefecture of Yunnan province. Zhonghua Liu Xing Bing Xue Za Zhi 2010, 31:997-1000. [in Chinese].
55. Lieberman P.M. Keeping it quiet: chromatin control of gammaherpesvirus latency. Nat Rev Microbiol 2013, 11:863-875.
56. Nitzsche A., Paulus C., Nevels M. Temporal dynamics of cytomegalovirus chromatin assembly in productively infected human cells. JVirol 2008, 82:11167-11180.
57. Hummel M., Yan S., Li Z., et al. Transcriptional reactivation of murine cytomegalovirus ie gene expression by 5-aza-2'-deoxycytidine and trichostatin A in latently infected cells despite lack of methylation of the major immediate-early promoter. JGen Virol 2007, 88:1097-1102.
58. Campbell J., Trgovcich J., Kincaid M., et al. Transient CD8-memory contraction: a potential contributor to latent cytomegalovirus reactivation. JLeukoc Biol 2012, 92:933-937.
59. Ogata M., Satou T., Kawano R., et al. High incidence of cytomegalovirus, human herpesvirus-6, and Epstein-Barr virus reactivation in patients receiving cytotoxic chemotherapy for adult T cell leukemia. JMed Virol 2011, 83:702-709.
60. Wang H., Liu X.X., Liu Y.X., et al. Incidence and risk factors of non-fatal injuries in Chinese children aged 0-6 years: a case-control study. Injury 2011, 42:521-524.
61. Seitanidis B. Acomparison of the Monospot with the Paul-Bunnell test in infectious mononucleosis and other diseases. JClin Pathol 1969, 22:321-323.
62. Glaser R., Kiecolt-Glaser J.K., Speicher C.E., et al. Stress, loneliness, and changes in herpesvirus latency. JBehav Med 1985, 8:249-260.
63. Padgett D.A., Sheridan J.F., Dorne J., et al. Social stress and the reactivation of latent herpes simplex virus type 1. Proc Natl Acad Sci USA 1998, 95:7231-7235. [Erratum appears in Proc Natl Acad Sci USA 1998;95(20):12070.].
64. Mehta S.K., Cohrs R.J., Forghani B., et al. Stress-induced subclinical reactivation of varicella zoster virus in astronauts. JMed Virol 2004, 72:174-179.
65. Bhamidipati C.M., LaPar D.J., Mehta G.S., et al. Albumin is a better predictor of outcomes than body mass index following coronary artery bypass grafting. Surgery 2011, 150:626-634.
66. Pierson D.L., Stowe R.P., Phillips T.M., et al. Epstein-Barr virus shedding by astronauts during space flight. Brain Behav Immun 2005, 19:235-242.
67. Mehta S.K., Crucian B.E., Stowe R.P., et al. Reactivation of latent viruses is associated with increased plasma cytokines in astronauts. Cytokine 2013, 61:205-209.
68. Battle J.D., Hewlett J.S. Hematologic changes observed after extracorporeal circulation during open-heart operations. Cleve Clin Q 1958, 25:112-115.
69. Holswade G.R., Engle M.A., Redo S.F., et al. Development of viral diseases and a viral disease-like syndrome after extracorporeal circulation. Circulation 1963, 27:812-815.
70. Seaman A.J., Starr A. Febrile postcardiotomy lymphocytic splenomegaly: a new entity. Ann Surg 1962, 156:956-960.
71. Ross B.A. Pyrexia after heart surgery due to virus infection transmitted by blood transfusion. Thorax 1964, 19:159-161.
72. Smith D.R. Asyndrome resembling infectious mononucleosis after open-heart surgery. Br Med J 1964, 1:945-948.
73. Perillie P.E., Glenn W.W. Fever, splenomegaly, lymphocytosis and eosinophilia. Yale J Biol Med 1962, 34:625-628.
74. Kääriäinen L., Klemola E., Paloheimo J. Rise of cytomegalovirus antibodies in an infectious-mononucleosis-like syndrome after transfusion. BMJ 1966, 1:1270-1272.
75. Adler S.P., Baggett J., McVoy M. Transfusion-associated cytomegalovirus infections in seropositive cardiac surgery patients. Lancet 1985, 326:743-746.
76. Domart Y., Trouillet J.L., Fagon J.Y., et al. Incidence and morbidity of cytomegaloviral infection in patients with mediastinitis following cardiac surgery. Chest 1990, 97:18-22. [see comments].
77. Abramson J.S., Mills E.L. Depression of neutrophil function induced by viruses and its role in secondary microbial infections. Rev Infect Dis 1988, 10:326-341.
78. Hamilton J.R., Overall J.C., Glasgow L.A. Synergistic effect on mortality in mice with murine cytomegalovirus and Pseudomonas aeruginosa, Staphylococcus aureus, or Candida albicans infections. Infect Immun 1976, 14:982-989.
79. Rand K.H., Merigan T.C. Cytomegalovirus: a not so innocent bystander. JAMA 1978, 240:2470-2471.
80. Dirbas F.M., Swain J.A. Disseminated cutaneous herpes zoster following cardiac surgery. JCardiovasc Surg (Torino) 1990, 31:531-532.
81. Godfrey E.K., Brown C., Stambough J.L. Herpes zoster-varicella complicating anterior thoracic surgery: 2 case reports. JSpinal Disord Tech 2006, 19:299-301.
82. Sachdeva S., Prasher P. Herpes zoster following saphenous venectomy for coronary bypass surgery. JCard Surg 2010, 25:28-29.
83. Nunez J., Chilet M., Sanchis J., et al. Prevalence and prognostic implications of active cytomegalovirus infection in patients with acute heart failure. Clin Sci 2010, 119:443-452.
84. Yamashiroya H.M., Ghosh L., Yang R., et al. Herpesviridae in the coronary arteries and aorta of young trauma victims. Am J Pathol 1988, 130:71-79.
85. Fabricant C.G., Fabricant J., Litrenta M.M., et al. Virus-induced atherosclerosis. JExp Med 1978, 148:335-340.
86. Span A.H., Van Boven C.P., Bruggeman C.A. The effect of cytomegalovirus infection on the adherence of polymorphonuclear leucocytes to endothelial cells. Eur J Clin Invest 1989, 19:542-548.
87. Aung A.K., Skinner M.J., Lee F.J., et al. Changing epidemiology of bloodstream infection pathogens over time in adult non-specialty patients at an Australian tertiary hospital. Commun Dis Intell 2012, 36:E333-341.
88. Epstein S.E., Zhu J., Najafi A.H., et al. Insights into the role of infection in atherogenesis and in plaque rupture. Circulation 2009, 119:3133-3141.
89. Mukherjee S., Allen R.M., Lukacs N.W., et al. STAT3-mediated IL-17 production by postseptic T cells exacerbates viral immunopathology of the lung. Shock 2012, 38:515-523.
90. Parfitt D.N. Herpes Zoster as a sequel to lightning trauma. Br Med J 1936, 1:111.
91. Liu X.F., Wang X., Yan S., et al. Epigenetic control of cytomegalovirus latency and reactivation. Viruses 2013, 5:1325-1345.
92. Constant E., Davis D.G., Maldonado W.E. Disseminated cytomegalovirus infection associated with death in a patient with severe facial injuries. Case report. Plast Reconstr Surg 1973, 51:336-339.
93. Guggenheimer J., Fletcher R.D. Traumatic induction of an intraoral reinfection with herpes simplex virus: report of a case. Oral Surg Oral Med Oral Pathol 1974, 38:546-549.
94. Purtilo D.T., Paquin L.A., Sakamoto K., et al. Persistent transfusion-associated infectious mononucleosis with transient acquired immunodeficiency. Am J Med 1980, 68:437-440.
95. Foley F.D., Greenawald K.A., Nash G., et al. Herpesvirus infection in burned patients. NEngl J Med 1970, 282:652-656.
96. Deepe G.S., MacMillan B.G., Linnemann C.C. Unexplained fever in burn patients due to cytomegalovirus infection. JAMA 1982, 248:2299-2301.
97. Kagan R.J., Naraqi S., Matsuda T., et al. Herpes simplex virus and cytomegalovirus infections in burned patients. JTrauma 1985, 25:40-45.
98. Kealey G.P., Bale J.F., Strauss R.G., et al. Cytomegalovirus infection in burn patients. JBurn Care Rehabil 1987, 8:543-545.
99. Bale J.F., Kealey G.P., Massanari R.M., et al. The epidemiology of cytomegalovirus infection among patients with burns. Infect Control Hosp Epidemiol 1990, 11:17-22.
100. Hayden F.G., Himel H.N., Heggers J.P. Herpesvirus infections in burn patients. Chest 1994, 106:15S-21S. [discussion: 34S-5S].
101. Bordes J., Gaillard T., Maslin J., et al. Cytomegalovirus infection monitored by quantitative real-time PCR in critically ill patients. Crit Care 2011, 15:412.
102. Limaye A.P., Kirby K.A., Rubenfeld G.D., et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 2008, 300:413-422.
103. Schroeder J.E., Tessone A., Angel M., et al. Disseminated Varicella infection in an adult burn victim-a transfused disease?. Burns 2009, 35:297-299.
104. Sheridan R.L., Weber J.M., Pasternak M.M., et al. A15-year experience with varicella infections in a pediatric burn unit. Burns 1999, 25:353-356.
105. Herpesvirus infection in burned patients. BMJ 1970, 2:618-619. [editorial].
106. Tenenhaus M., Rennekampff H.O., Pfau M., et al. Cytomegalovirus and burns: current perceptions, awareness, diagnosis, and management strategies in the United States and Germany. JBurn Care Res 2006, 27:281-288.
107. D'Avignon L.C., Hogan B.K., Murray C.K., et al. Contribution of bacterial and viral infections to attributable mortality in patients with severe burns: an autopsy series. Burns 2010, 36:773-779.
108. Kobayashi H., Kobayashi M., McCauley R.L., et al. Cadaveric skin allograft-associated cytomegalovirus transmission in a mouse model of thermal injury. Clin Immunol 1999, 92:181-187.
109. Kealey G.P., Aguiar J., Lewis R.W., et al. Cadaver skin allografts and transmission of human cytomegalovirus to burn patients. JAm Coll Surg 1996, 182:201-205.
110. Fidler P.E., Mackool B.T., Schoenfeld D.A., et al. Incidence, outcome, and long-term consequences of herpes simplex virus type 1 reactivation presenting as a facial rash in intubated adult burn patients treated with acyclovir. JTrauma 2002, 53:86-89.
111. Nash G., Asch M.J., Foley F.D., et al. Disseminated cytomegalic inclusion disease in a burned adult. JAMA 1970, 214:587-588.
112. Tuxen D.V., Cade J.F., McDonald M.I., et al. Herpes simplex virus from the lower respiratory tract in adult respiratory distress syndrome. Am Rev Respir Dis 1982, 126:416-419.
113. Byers R.J., Hasleton P.S., Quigley A., et al. Pulmonary herpes simplex in burns patients. Eur Respir J 1996, 9:2313-2317.
114. Kalil A.C., Florescu D.F. Prevalence and mortality associated with cytomegalovirus infections in non-immunosuppressed ICU patients. Crit Care Med 2009, 37:2350-2358.
115. Cook C.H., Yenchar J.K., Kraner T.O., et al. Occult herpes family viruses may increase mortality in critically ill surgical patients. Am J Surg 1998, 176:357-360.
116. Cook C.H., Martin L.C., Yenchar J.K., et al. Occult herpes family viral infections are endemic in critically ill surgical patients. Crit Care Med 2003, 31:1923-1929.
117. Aarts M.A., Granton J., Cook D.J., et al. Empiric antimicrobial therapy in critical illness: results of a surgical infection society survey. Surg Infect (Larchmt) 2007, 8:329-336.
118. Docke W.D., Prosch S., Fietze E., et al. Cytomegalovirus reactivation and tumour necrosis factor. Lancet 1994, 343:268-269.
119. Seckert C.K., Griessl M., Buttner J.K., et al. Immune surveillance of cytomegalovirus latency and reactivation in murine models: link to memory inflation. Cytomegaloviruses 2013, 374-416. Caister Academic Press, Norfolk (United Kingdom). M.J. Reddehase (Ed.).
120. Kutza A.S., Muhl E., Hackstein H., et al. High incidence of active cytomegalovirus infection among septic patients. Clin Infect Dis 1998, 26:1076-1082.
121. Heininger A., Jahn G., Engel C., et al. Human cytomegalovirus infections in nonimmunosuppressed critically ill patients. Crit Care Med 2001, 29:541-547.
122. Jaber S., Chanques G., Borry J., et al. Cytomegalovirus infection in critically ill patients: associated factors and consequences. Chest 2005, 127:233-241.
123. von Muller L., Klemm A., Weiss M., et al. Active cytomegalovirus infection in patients with septic shock. Emerg Infect Dis 2006, 12:1517-1522.
124. Ziemann M., Sedemund-Adib B., Reiland P., et al. Increased mortality in long-term intensive care patients with active cytomegalovirus infection. Crit Care Med 2008, 36:3145-3150.
125. Chiche L., Forel J.M., Roch A., et al. Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients. Crit Care Med 2009, 37:1850-1857.
126. Chilet M., Aguilar G., Benet I., et al. Virological and immunological features of active cytomegalovirus infection in nonimmunosuppressed patients in a surgical and trauma intensive care unit. JMed Virol 2010, 82:1384-1391.
127. Heininger A., Haeberle H., Fischer I., et al. Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis. Crit Care 2011, 15:R77.
128. Coisel Y., Bousbia S., Forel J.M., et al. Cytomegalovirus and herpes simplex virus effect on the prognosis of mechanically ventilated patients suspected to haveventilator-associated pneumonia. PLoS One 2012, 7:e51340. [Electronic Resource].
129. Papazian L., Fraisse A., Garbe L., et al. Cytomegalovirus. An unexpected cause of ventilator-associated pneumonia. Anesthesiology 1996, 84:280-287.
130. Chatterjee S.N., Fiala M., Weiner J., et al. Primary cytomegalovirus and opportunistic infections. Incidence in renal transplant recipients. JAMA 1978, 240:2446-2449.
131. Bouza E., Giannella M., Torres M.V., et al. Herpes simplex virus: a marker of severity in bacterial ventilator-associated pneumonia. JCrit Care 2011, 26:432.e1-432.e6.
132. Schuller D. Lower respiratory tract reactivation of herpes simplex virus. Comparison of immunocompromised and immunocompetent hosts. Chest 1994, 106:3S-7S. [discussion: 34S-5S].
133. Centers for Disease Control and Prevention (CDC) Vital signs: central line-associated blood stream infections-United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep 2011, 60:243-248.
134. Deback C., Luyt C.E., Lespinats S., et al. Microsatellite analysis of HSV-1 isolates: from oropharynx reactivation toward lung infection in patients undergoing mechanical ventilation. JClin Virol 2010, 47:313-320.
135. Simoons-Smit A.M., Kraan E.M., Beishuizen A., et al. Herpes simplex virus type 1 and respiratory disease in critically-ill patients: Real pathogen or innocent bystander?. Clin Microbiol Infect 2006, 12:1050-1059.
136. Luyt C.E., Combes A., Deback C., et al. Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation. Am J Respir Crit Care Med 2007, 175:935-942.
137. van den Brink J.W., Simoons-Smit A.M., Beishuizen A., et al. Respiratory herpes simplex virus type 1 infection/colonisation in the critically ill: marker or mediator?. JClin Virol 2004, 30:68-72.
138. Scheithauer S., Manemann A.K., Kruger S., et al. Impact of herpes simplex virus detection in respiratory specimens of patients with suspected viral pneumonia. Infection 2010, 38:401-405.
139. Engelmann I., Gottlieb J., Meier A., et al. Clinical relevance of and risk factors for HSV-related tracheobronchitis or pneumonia: results of an outbreak investigation. Crit Care 2007, 11:R119.
140. Apisarnthanarak A., Holzmann-Pazgal G., Hamvas A., et al. Antimicrobial use and the influence of inadequate empiric antimicrobial therapy on the outcomes of nosocomial bloodstream infections in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2004, 25:735-741.
141. Linssen C.F., Jacobs J.A., Stelma F.F., et al. Herpes simplex virus load in bronchoalveolar lavage fluid is related to poor outcome in critically ill patients. Intensive Care Med 2008, 34:2202-2209.
142. Glaser R., Pearson G.R., Jones J.F., et al. Stress-related activation of Epstein-Barr virus. Brain Behav Immun 1991, 5:219-232.
143. Honda H., Krauss M.J., Coopersmith C.M., et al. Staphylococcus aureus nasal colonization and subsequent infection in intensive care unit patients: does methicillin resistance matter?. Infect Control Hosp Epidemiol 2010, 31:584-591.
144. Drazin D., Hanna G., Shweikeh F., et al. Varicella-zoster-mediated radiculitis reactivation following cervical spine surgery: case report and review of the literature. Case Rep Infect Dis 2013, 2013:647486.
145. Anderson M.D., Tummala S. Herpes myelitis after thoracic spine surgery. JNeurosurg Spine 2013, 18:519-523.
146. Grauvogel J., Vougioukas V.I. Herpes radiculitis following surgery for symptomatic cervical foraminal stenosis. Can J Neurol Sci 2008, 35:661-663.
147. Weiss R. Herpes zoster following spinal surgery. Clin Exp Dermatol 1989, 14:56-57.
148. Miller A.E. Selective decline in cellular immune response to varicella-zoster in the elderly. Neurology 1980, 30:582-587.
149. Cohen J.I., Brunell P.A., Straus S.E., et al. Recent advances in varicella-zoster virus infection. Ann Intern Med 1999, 130:922-932.
150. Razonable R.R., Fanning C., Brown R.A., et al. Selective reactivation of human herpesvirus 6 variant A occurs in critically ill immunocompetent hosts. JInfect Dis 2002, 185:110-113. [see comment].
151. Tang Y.W., Johnson J.E., Browning P.J., et al. Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis. JClin Microbiol 2003, 41:2633-2640.
152. Machens A., Bloechle C., Achilles E.G., et al. Toxic megacolon caused by cytomegalovirus colitis in a multiply injured patient. JTrauma 1996, 40:644-646.
153. Heininger A., Vogel U., Aepinus C., et al. Disseminated fatal human cytomegalovirus disease after severe trauma. Crit Care Med 2000, 28:563-566.
154. Wildenauer R., Suttorp A.C., Kobbe P. Cytomegalievirus-Kolitis bei einer polytraumatisierten alteren Patientin. Dtsch Med Wochenschr 2008, 133:2383-2386. [in German].
155. Cheung A.N., Ng I.O. Cytomegalovirus infection of the gastrointestinal tract in non-AIDS patients. Am J Gastroenterol 1993, 88:1882-1886.
156. Chamberlain R.S., Atkins S., Saini N., et al. Ileal perforation caused by cytomegalovirus infection in a critically ill adult. JClin Gastroenterol 2000, 30:432-435.
157. Page M.J., Dreese J.C., Poritz L.S., et al. Cytomegalovirus enteritis: a highly lethal condition requiring early detection and intervention. Dis Colon Rectum 1998, 41:619-623.
158. Murray R.N., Parker A., Kadakia S.C., et al. Cytomegalovirus in upper gastrointestinal ulcers. JClin Gastroenterol 1994, 19:198-201.
159. Blackman E., Vimadalal S., Nash G. Significance of gastrointestinal cytomegalovirus infection in homosexual males. Am J Gastroenterol 1984, 79:935-940.
160. Katzoli P., Sakellaris G., Ergazaki M., et al. Detection of herpes viruses in children with acute appendicitis. JClin Virol 2009, 44:282-286.
161. Cook C., Zhang X., McGuinness B., et al. Intra-abdominal bacterial infection reactivates latent pulmonary cytomegalovirus in immunocompetent mice. JInfect Dis 2002, 185:1395-1400.
162. Frecentese D.F., Cogbill T.H. Spontaneous splenic rupture in infectious mononucleosis. Am Surg 1987, 53:521-523.
163. Rogues A.M., Dupon M., Cales V., et al. Spontaneous splenic rupture: an uncommon complication of cytomegalovirus infection. JInfect 1994, 29:83-85.
164. Alliot C., Beets C., Besson M., et al. Spontaneous splenic rupture associated with CMV infection: report of a case and review. Scand J Infect Dis 2001, 33:875-877.
165. Horwitz C.A., Henle W., Henle G., et al. Clinical and laboratory evaluation of cytomegalovirus-induced mononucleosis in previously healthy individuals. Report of 82 cases. Medicine (Baltimore) 1986, 65:124-134.
166. Al-Tawfiq J.A., Abed M.S., Al-Yami N., et al. Promoting and sustaining a hospital-wide, multifaceted hand hygiene program resulted in significant reduction in health care-associated infections. Am J Infect Control 2013, 41:482-486.
167. Baumgartner J.D., Glauser M.P., Burgo-Black A.L., et al. Severe cytomegalovirus infection in multiply transfused, splenectomized, trauma patients. Lancet 1982, 2:63-66.
168. Okun D.B., Tanaka K.R. Profound leukemoid reaction in cytomegalovirus mononucleosis. JAMA 1978, 240:1888-1889.
169. Langenhuijsen M.M., van Toorn D.W. Splenectomy and the severity of cytomegalovirus infection. Lancet 1982, 2:820.
170. Assy N., Gefen H., Schlesinger S., et al. Reactivation versus primary CMV infection after splenectomy in immunocompetent patients. Dig Dis Sci 2007, 52:3477-3480.
171. Forster M.R., Trgovcich J., Zimmerman P., et al. Antiviral prevention of sepsis induced cytomegalovirus reactivation in immunocompetent mice. Antiviral Res 2010, 85:496-503.
172. Cook C. Cytomegalovirus reactivation and mortality during critical illness: a $64,000 question. Crit Care Med 2009, 37:2475-2476.
173. Cook C.H., Trgovcich J. Cytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges. Antiviral Res 2011, 90:151-159.
174. Camps K., Jorens P.G., Demey H.E., et al. Clinical significance of herpes simplex virus in the lower respiratory tract of critically ill patients. Eur J Clin Microbiol Infect Dis 2002, 21:758-759.
175. Tuxen D.V. Prevention of lower respiratory herpes simplex virus infection with acyclovir in patients with adult respiratory distress syndrome. Chest 1994, 106:28S-33S.
176. Haik J., Weissman O., Stavrou D., et al. Is prophylactic acyclovir treatment warranted for prevention of herpes simplex virus infections in facial burns? A review of the literature. JBurn Care Res 2011, 32:358-362.
177. Bourdarias B., Perro G., Cutillas M., et al. Herpes simplex virus infection in burned patients: epidemiology of 11 cases. Burns 1996, 22:287-290.